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Abstract
We present a quantitative model for the binding of divalent ligand–receptor systems. We study the influence of length and flexi-
bility of the spacers on the overall binding affinity and derive general rules for the optimal ligand design. To this end, we first
compare different polymeric models and determine the probability to simultaneously bind to two neighboring receptor binding
pockets. In a second step the binding affinity of divalent ligands in terms of the IC50 value is derived. We find that a divalent ligand
has the potential to bind more efficiently than its monovalent counterpart only, if the monovalent dissociation constant is lower than
a critical value. This critical monovalent dissociation constant depends on the ligand-spacer length and flexibility as well as on the
size of the receptor. Regarding the optimal ligand-spacer length and flexibility, we find that the average spacer length should be
equal or slightly smaller than the distance between the receptor binding pockets and that the end-to-end spacer length fluctuations
should be in the same range as the size of a receptor binding pocket.
Introduction
Multivalency is a common design principle in biological
systems. The simultaneous binding of several, relatively weakly
binding partners is a widely used strategy to strengthen the
overall binding affinity [1-3]. Multivalency is believed to play
an important role in evolutionary processes, since the collective
interaction of several rather simple ligands makes the develop-
ment of more complex binding partners with a higher binding
affinity unnecessary [2]. Also in drug design, the synthesis of
artificial multivalent ligands is a promising route to increase the
binding affinity or to reduce the amount of substance required
for treatment [4-7].
The term multivalency is used for systems that consist of
several identical binding partners. Thereby, the larger binding
partner, for example a protein, is commonly denoted as
receptor, whereas the smaller binding partner, for instance an
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Figure 1: (a) Schematic of a divalent ligand–receptor system: The receptor has two binding pockets with a distance d from each other and a binding
range σ. The ligand consists of two identical ligand units, connected via a spacer of contour length L. The end-to-end distance of the ligand is denoted
as r. (b) Binding modes of a divalent ligand: (1) One ligand occupies one binding pocket. (2) Two ligands occupy two binding pockets. (3) One ligand
occupies both binding pockets.
enzyme or a single molecule, is denoted as ligand. The binding
strength of a multivalent structure significantly depends on
details of the presentation of ligands and receptors [1]. Each
multivalent ligand consists of several monovalent ligands that
are connected via a scaffold. The binding affinity of such a
multivalent ligand is determined by the interplay between gain
in binding energy and loss of entropy associated with con-
formational degrees of freedom. The more flexible the scaffold
is, the better it can adapt to the geometry of the receptor, but the
more pronounced on the other hand is the entropy penalty. This
simple, qualitative argument shows that the careful choice of
the ligand scaffold is essential, in order to benefit from multiva-
lent enhancement. It is therefore desirable to derive a model that
allows one to predict the binding affinity of a given ligand-scaf-
fold construct. Several theoretical studies have been dedicated
to study the interaction between multi- and polyvalent ligands
with receptors arranged on planar surfaces [8-13]. The over-
whelming variety of multivalent ligand architectures that range
from small divalent ligands to densely packed nanoparticles, led
to different approaches to describe multivalency, depending on
the size and valency of the system. Several studies aimed to
treat ligand–receptor systems with different structures and
valencies in the framework of a generalized theory [14,15].
The smallest multivalent system consists of a divalent ligand
that interacts with a divalent receptor. Despite its seeming
simplicity, the rational design of divalent ligands is still chal-
lenging [16-19]. In this paper we examine a general model for a
divalent receptor–ligand system in order to estimate the binding
affinity from the dissociation constant of the monovalent ligand
and the length and flexibility of the ligand spacer.
Figure 1a schematically depicts a divalent ligand–receptor
system. The receptor possesses two binding pockets at a dis-
tance d from each other. A binding range of σ characterizes
each binding pocket. The divalent ligand consists of two ligand
units that are connected via a spacer. The contour length of the
spacer is denoted as L. There are three different modes in which
a divalent ligand can bind to a divalent receptor. Each of these
binding modes has a different number of realization possibili-
ties as summarized in Figure 1b: (1) One binding pocket is
occupied by one ligand. (2) Two binding pockets are occupied
by two ligands. (3) Two binding pockets are occupied by one
ligand. The binding affinity in the latter case is strongly influ-
enced by the conformational linker properties, which can be
conveniently discussed in terms of the effective concentration.
The effective concentration describes the local concentration of
one ligand unit close to one binding pocket, if the other ligand
unit is assumed to be bound to the other binding pocket. The
effective concentration thus corresponds to the probability that
the spacer extends to an end-to-end distance that is equal to d, if
spacer–receptor interactions are neglected [20]. In the first
section different models for the effective concentration are
discussed, with particular focus on the influence of the spacer
stiffness and the binding range σ.
For each binding mode depicted in Figure 1b the following
dissociation constants are derived: (1) The dissociation constant
is equal to the dissociation constant of the monovalent ligand,
Kmono, multiplied by a factor of 1/α, which accounts for the
reduced degrees of freedom of the spacer, since it cannot pene-
trate the receptor. The parameter α can adopt value between 0
and 1. In the limiting case, in which the spacer sterically
inhibits the ligand unit from binding to the receptor, α becomes
0. In the hypothetical case, in which the conformational degrees
of freedom of the spacer do not reduce at all when binding
to a receptor, the parameter α becomes 1. (2) Each ligand
contributes with a factor of Kmono/α to the dissociation constant.
(3) The dissociation constant consists of the monovalent disso-
ciation constant for each ligand times the probability that the
spacer bridges the two binding pockets. A detailed derivation of
the dissociation constants is presented in Supporting Informa-
tion File 1. Furthermore, Figure 1b summarizes the combinato-
rial factors for each binding mode that count the number of
equivalent permutations. We regard the divalent ligands as
distinguishable, we note in passing that this could reflect poly-
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meric spacers that exhibit chemical asymmetry. Our final
results do not depend on whether we assume indistinguishable
ligand units or not.
Results and Discussion
Effective concentration – wormlike-chain
model
Samuel and Sinha [21] developed an exact method to describe
the conformational statistics of wormlike chains for the whole
range from short to long polymers. Their model is applied here
to determine the effective concentration Ceff, which is equiva-
lent to the end-to-end distance probability distribution, with the
normalization . An example is shown in
Figure 2. The length of the fully extended spacer L is set to
5 nm. The effective concentration, i.e., the probability that a
spacer of given length and stiffness extends to a certain end-to-
end-distance d, is shown for different persistence lengths lp. The
flexible spacer (lp = 1 nm) exhibits a maximum at d = 0.
Furthermore, the distribution is very broad, indicating that a
flexible spacer can easily bridge two binding pockets, even if
the spacer length does not exactly match the inter binding
pocket distance d. For a slightly stiffer spacer (lp = 1.3 nm), Ceff
is even broader, but the maximum of Ceff is reduced by a factor
of about one half and the distribution shows a plateau between
d = 0 nm and d = 3 nm. For stiff spacers (lp = 5 nm and
lp = 10 nm), Ceff exhibits a narrow peak close to the fully
extended state. In the bound state, the ligand units explore the
range σ of a receptor binding pocket. Hence, it is useful to
consider the effective concentration averaged over the range of
both binding pockets. We denote the averaged effective concen-
tration as  with
(1)
with Vbp the volume of one binding pocket, r1 and r2 the posi-
tions within the first and second binding pocket. We introduce
the connecting vector r = |r1 − r2| and express r in spherical
coordinates:
(2)
with r the distance between the two ligand units, θ the angle
between r and the connecting vector of the binding pocket
midpoints and φ an angle that describes the rotation around the
connecting vector of the binding pocket midpoints. Since the
range of the binding pocket σ is assumed to be much smaller
than the distance between the binding pockets d, we conclude
that the integrals in Equation 2 approximately factorize.
Furthermore, the size of the binding pocket limits the range
over which the angle θ can vary. In the range, where r varies
between d − σ and d + σ, the angle θ can adopt a maximum
value of arctan(σ/r). The upper limit for the integration over θ
then reads
The integration over r can now be described by variations of r
in the range from d − σ and d + σ. With these approximations,
Equation 2 can be written as an effective average over one
dimension:
(3)
In Figure 2, the averaged effective concentration is shown as
green, dashed lines, with σ = 0.25 nm. A flexible spacer can
easily extend to all positions within the binding pockets. Hence,
one cannot observe any significant difference between  and
Ceff. In contrast, a very stiff spacer cannot explore the whole
binding pocket. Therefore, the averaged effective concentration
is reduced and slightly broadened around its maximum, as can
be seen best in Figure 2 for lp = 10 nm.
Figure 2: Effective concentration Ceff of spacers with a contour length
of L = 5 nm as a function of the distance between the binding pockets.
The effective concentration is shown for different spacer stiffness, in
terms of different persistence lengths between lp = 1–10 nm (contin-
uous lines). The effective concentration , averaged over a binding
pocket range σ = 0.25 nm, is shown as green, dashed lines.
Beilstein J. Org. Chem. 2015, 11, 804–816.
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Figure 3: Average end-to-end distance, rete, end-to-end-distance
where the effective concentration Ceff exhibits a maximum, rmax, vari-
ance of the end-to-end distance distribution, Δr, maximum of the effec-
tive concentration,  (continuous line), and effective concentration
at rete, Ceff(rete) (dashed line), in dependence of the persistence length
lp. All lengths are measured in units of the spacer contour length L.
Spacers with a persistence length lp < 0.26L are called flexible.
Spacers with a persistence length lp > 0.26L are called stiff. For stiff
spacers the relation between Δr/L and the persistence length is well
described by Δr/L = 0.1L/lp (dotted line).
Figure 3 summarizes the averaged end-to-end distance rete, the
end-to-end distance that corresponds to a maximum in Ceff,
rmax, the variance of the end-to-end distance distribution Δr, the
maximum of the effective concentration  and the effective
concentration at rete, Ceff(rete), for different persistence lengths.
The influence of the binding range σ is neglected here. The
average end-to-end distance rete increases monotonically with
increasing persistence length and approaches the contour length
L for very stiff spacers. All other quantities reveal a clear-cut
difference between the flexible and stiff limits. The classifica-
tion “flexible” and “stiff” is, of course, to some degree arbi-
trary. We here apply a definition that is based on the disconti-
nuity in rmax, which is the most prominent feature in the chain
observables. In the following, spacers with a persistence length
smaller than 0.26L are called flexible and spacers with a persis-
tence length larger than 0.26L are called stiff. The variance Δr
exhibits a maximum around lp = 0.26L, for stiffer spacers Δr
reduces rapidly. As can be seen in Figure 3, the variance Δr
depends on the persistence length as Δr = 0.1L2/lp (dotted line)
for stiff spacers. Mac Kintosh et al. found the same scaling for
the fluctuations of semiflexible polymers [22]. The maximum
of the effective concentration  (continuous line) as well as
the effective concentration at rete, Ceff(rete), (dashed line) are
minimal in the same region where Δr is maximal. Since for a
stiff spacer rmax and rete are both close to L,  and Ceff(rete)
exhibit only small deviations from each other. For flexible
spacers on the other hand, Ceff(rete) can be much smaller than
the maximal effective concentration. The results presented here
show that neither the persistence length nor the contour length
alone are sufficient to describe the behavior of the effective
concentration, rather the ratio between persistence length and
contour length, lp/L, characterizes the conformational behavior.
Note that for a typical receptor distance of d = 5 nm, DNA
molecules with lp = 53 nm are characterized by a ratio lp/L ≈ 10
and thus correspond to the very stiff limit. Polyethylene glycol
(PEG) with a persistence length of about lp = 0.38 nm on the
other hand is characterized by a ratio smaller than lp/L = 0.08
and thus correspond to the flexible limit [23].
Effective concentration – harmonic spring
and Gaussian chain approximation
The wormlike-chain model requires complex numerical analysis
for the calculation of conformational chain properties. In a
simplified model the spacer statistics can be described as a
harmonic spring or a Gaussian chain with suitably chosen para-
meters. The advantage of this model is that the effective
concentration can be derived in closed form. Furthermore, we
show that despite its simplified assumptions the model accu-
rately reproduces the effective concentration Ceff(rete) for flex-
ible as well as for stiff spacers.
Stiff spacer – harmonic spring approximation
A stiff spacer is on average extended to almost its full length.
The fluctuations around its most probable end-to-end distance
r0 are assumed to be much smaller than the contour length L.
We approximate the free energy F, similar to a harmonic spring,
as
(4)
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with k the effective spring constant and d the end-to-end dis-
tance. The effective concentration Ceff(d), i.e., the normalized
probability to extend the spacer to a certain end-to-end distance
d, reads
(5)
The averaged effective concentration  as defined in
Equation 3 then becomes:
(6)
In order to express the effective concentration in term of the
experimentally more relevant average end-to-end distance rete
and the variance Δr, we first have to determine the relation
between rete and Δr on the one side and k and r0 on the other
side.
From the free energy F in Equation 4 the average end-to-end





Note that according to our notation, the average end-to-end dis-
tance rete is not equivalent to the root mean squared end-to-end
distance . The variance Δr hence reads:
(11)
(12)
Using Equation 6 and the results for Δr and rete in terms of
the model parameters k and r0 in the stiff spacer limit
, the averaged effective concentration reads:
(13)
For a fixed distance d that has to be spanned by the ligand, the
effective concentration becomes maximal for rete = d and we
obtain, for this optimized spacer length, the result:
(14)
Furthermore, we can differentiate between two cases: 1) the
chain fluctuations are smaller than the binding range (Δr << σ)
and 2) the chain fluctuations are larger than the binding range
(Δr >> σ), leading to
(15)
(16)
We see that in both limits, the maximal effective concentration
decreases quadratically with the distance d. More importantly,
increasing the stiffness of the spacer (decreasing Δr) increases
the effective concentration, but only until the variance Δr
Beilstein J. Org. Chem. 2015, 11, 804–816.
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Figure 4: Effective concentration for the optimized average end-to-end distance rete=d for the wormlike chain model (continuous line) and the
harmonic spring model Equation 17 (dotted line, subfigure a) as well as the Gaussian-chain model Equation 25 (dotted line, subfigure b). In the calcu-
lation, we vary the ratio between persistence length and contour length lp/L, which results in different ratios Δr/d and d/L, respectively. (a) Stiff spacers
are well approximated by Equation 17. (b) Flexible spacers are well approximated by Equation 25.
becomes of the same order as the binding range σ. For even
stiffer spacers the effective concentration stagnates, as can be
seen in Equation 15. We conclude that it is not advantageous to
increase the spacer stiffness beyond the situation where the end-
to-end distance variance Δr becomes smaller than the receptor
binding range σ. To compare this model with the wormlike-
chain model Equation 16 is rewritten as:
(17)
As can be seen in Figure 4a Equation 17 describes the behavior
of stiff wormlike chains very well.
Flexible spacer – Gaussian-chain approximation
The effective concentration of flexible polymers is often
modeled by a Gaussian chain [11,20,24] with the free energy:
(18)
using the mean squared end-to-end distance . The end-to-
end distance rete and the variance Δr can be expressed in terms
of the mean squared end-to-end distance:
(19)
(20)
As a consequence the end-to-end distance rete and the variance
Δr are related as
(21)
Furthermore, the mean squared end-to-end distance can be
written as
(22)
with b being the Kuhn length of one chain segment and N the
number of segments.
We here present the effective concentration as a function of d
and rete.
(23)
Using Equations 19–22, rete can as well be substituted by ,
Δr or N.
Note that the effective concentration of a flexible spacer with
fixed contour length L is maximal at a distance d = 0, as shown
in Figure 2. In contrast, for a given distance d the effective
concentration becomes maximal at . In other
Beilstein J. Org. Chem. 2015, 11, 804–816.
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words, the average end-to-end distance of an optimized flexible
spacer is smaller than the distance between the binding pockets
by a factor of :
(24)
Since we consider the fluctuations of a flexible chain much
larger than the range of the binding pocket, we neglect the influ-
ence of σ on the effective concentration. In order to compare the
behavior of a Gaussian chain with the results for a flexible
wormlike chain, Equation 24 is rewritten as:
(25)
In Figure 4b, Equation 25 is shown together with the numerical
results from the wormlike chain model obtained in the previous
section. The two models show good agreement in the flexible
limit, as expected.
Conformational degrees of freedom of a teth-
ered spacer
If one ligand unit is bound to one of the binding pockets, the
conformational degrees of freedom of the spacer are reduced,
since it cannot penetrate the receptor surface. We quantify this
reduction by the parameter α, which describes the ratio between
the partition function of a tethered and a free spacer. The value
of α depends on the shape of the receptor and the flexibility of
the spacer. To estimate the typical magnitude of α we consider
as limiting cases a stiff rod as well as a flexible Gaussian chain
tethered to a planar surface.
Stiff spacer
For a stiff rod attached with one end to a planar surface, the
parameter α becomes α = 1/2, since the rod can only explore
one half space.
Flexible spacer
As a second example we discuss a Gaussian chain. Equiva-
lently to Equation 23 the normalized probability that a Gaussian
chain consisting of N segments extends to an end-to-end dis-
tance r with b being the length of one segment reads in free
space:
(26)
We now assume that one end of the chain is attached to the
surface. Similar to the considerations made for a stiff rod, we
approximate the probability that the first segment does not
penetrate the surface by a factor 1/2. The probability distribu-
tion for the remaining N − 1 segments then reads:
(27)
with ρ the component of the end-to-end vector parallel to the
surface and z the height above the surface. The last term in
Equation 27 ensures that the chain does not penetrate the
surface (P′(ρ,z = 0,N) = 0). To obtain the parameter α, P′ has to
be integrated over one half space:
(28)
In the limit of a long chain (N >> 1), Equation 28 can be
approximated as:
(29)
A PEG spacer with b = 0.38 nm requires 30–800 segments to
adopt an average end-to-end distance of 2 to 10 nm. In this
range α varies between 0.02 and 0.13.
Binding affinity
With the effective concentration and a parameterization for the
reduction of the conformational degrees of freedom of the
spacer at hand, we now can examine the binding affinity of a
divalent ligand. A common way to quantify the binding affinity
of a multivalent ligand is the so-called IC50 value, the ligand (or
inhibitor) concentration at half maximal inhibition. In a first
step we want to re-derive the relation between the IC50 value
and the dissociation constant of a monovalent ligand [25,26].
Beilstein J. Org. Chem. 2015, 11, 804–816.
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Monovalent ligand
In the reaction , the dissociation constant
Kmono of a monovalent ligand interacting with a monovalent
receptor is defined as
(30)
with [L] and [R] being the concentration of unbound ligands
and unbound receptors and [RL] the concentration of bound
ligands or equivalently the concentration of bound receptors.
If half of all receptors are occupied, which defines the IC50
condition, the other half must be unbound and as a conse-
quence [R] = [RL]. From Equation 30 we see that under IC50
conditions the dissociation constant equals the concentration of
unbound ligands:
(31)
with the index 50 indicating that the IC50 condition is fulfilled.
In the monovalent case exactly one ligand binds to one receptor.
Thus, the concentration of bound ligands under IC50 conditions
is given by half the total receptor concentration:
(32)
with [R]0 = [R] + [RL] the total receptor concentration.
Combining Equation 31 and Equation 32 the IC50 value is
obtained as [25]:
(33)
In the limit of dilute receptor conditions ([R]0 << Kmono) the
IC50 value is a good approximation for the dissociation
constant, and we find:
(34)
Divalent ligand
In analogy to the monovalent case, we now derive an expres-
sion for the IC50 value of a divalent ligand. There are different
ways of defining half maximal inhibition for divalent receptors.
We first adopt a heuristic definition where half of all receptor
binding pockets are occupied by a ligand unit. This definition is
most relevant for competitive binding assays, for instance
surface plasmon resonance measurements [27], since the
measured signal in a competitive binding assay is related to the
number of occupied binding pockets. Later, we also define a
situation in which at least one ligand unit is bound to half of all
receptors as IC50 condition, which mimics non-competitive
binding assays, as for instance hemagglutination assays [28]. In
non-competitive binding assays the number of bound ligands
rather than the number of occupied binding pockets is
measured. In general the concentration of occupied binding
pockets [bp]occ of divalent receptors reads:
(35)
with [RLn] being the concentration of bound ligand–receptor
pairs, with n referring to the three binding modes summarized
in Figure 1b. Each term on the right hand side of Equation 35
has two prefactors. The first prefactor counts the number of
occupied binding pockets per receptor and the second prefactor
counts the permutations due to the distinguishability of the
ligand units and the receptor binding pockets (see Figure 1b).
Note that the number of permutations presented in Figure 1b
and Equation 35, are obtained for distinguishable ligand units.
For indistinguishable ligand units the number of permutations in
each binding mode is reduced. At the same time the dissocia-
tion constant of a ligand with indistinguishable ligand units is
reduced by the same factor. Hence, the overall concentration of
bound ligands does not change. A detailed derivation of the
dissociation constants for each binding mode is presented in
Supporting Information File 1.
In the same way the total concentration of binding pockets,
[bp]0, can be obtained as
(36)





In order to discuss also the IC50 condition for non-competitive
binding assays we derive the concentration of receptors with at




With Equations 35–38 the IC50 condition for competitive and
non-competitive binding is expressed as given in Equation 39
and Equation 40.
In analogy to the monovalent case we define the multivalent
dissociation constant Kmulti as the concentration of free ligand
under IC50 conditions, as defined in Equation 39 and
Equation 40.
Equation 41 and Equation 42 show the multivalent dissociation
constant Kmulti in case of competitive binding and non-competi-
tive binding, respectively.
(41)
Competitive and non-competitive binding exhibit the same
qualitative behavior for large effective concentrations. We
therefore limit the further discussion to competitive binding, as
given in Equation 41.
As one would intuitively expect, the multivalent dissociation
constant Kmulti becomes proportional to the monovalent dissoci-
ation constant, if the effective concentration is low, i.e., if
. In contrast, the multivalent dissociation constant
Beilstein J. Org. Chem. 2015, 11, 804–816.
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(43)
decreases, if the dissociation constant of the monovalent ligand
is small and if the effective concentration, i.e., the probability to
connect two binding pockets, is large.
To determine the total ligand concentration we first have to
derive the concentration of bound ligand [L]bound as shown in
Equation 43.
Using Equation 38 and 43, a relation between the concentration
of bound ligands and the total receptor concentration under IC50
conditions is obtained as
(44)
(45)
where we note that that ψ is a coefficient that varies between 1
and 5/4. Similar to the results for monovalent receptor–ligand
systems in Equation 34, the IC50 value becomes equivalent to
the multivalent dissociation constant, in the limit of low
receptor concentrations, i.e., for [R]0 << Kmulti:
(46)
To compare monovalent and multivalent ligands we use the
relative binding affinity (RBA), which we define as
(47)
Here, the factor 2 accounts for the valency of the ligand and
ensures that the concentration of ligand units are compared. The
larger the RBA the better is the divalent ligand. For RBA = 1 the
same concentration of mono- and divalent ligand units, taking
into account that a divalent ligand consist of two ligand units, is
required to occupy half of the receptor binding pockets. For
RBA < 1 the monovalent ligand binds better than the divalent
ligand. In this case the loss in entropy of the spacer is larger
Figure 5: Relative binding affinity (RBA) of a divalent ligand in depend-
ence of the end-to-end distance of the spacer rete from Equation 47.
The three different ligand–spacer constructs are schematically
depicted in the insets. The binding pockets are separated by d = 5 nm.
Each binding pocket has a binding range of σ = 0.1 nm. (a) The ligand
units are directly attached to a stiff DNA spacer, characterized by a
persistence length lp = 53 nm. (b) The ligand units are attached to a
stiff DNA spacer with flexible linker chain, leading to an end-to-end dis-
tance fluctuation of Δr = 0.5 nm. (c) The ligand units are connected via
a flexible spacer.
than the gain in binding energy due to the multiple binding
of ligand units. Inserting the effective concentration from
Equation 13 and Equation 23 into Equation 41 and Equation 47,
the RBA  can be calculated for any given divalent
ligand–receptor pair. As an example the RBA is depicted for
different spacers and different values of Kmono in Figure 5. We
here assume that the receptor is well described by a large,
planar surface. Hence, the parameter α is approximated by 1/2
for stiff spacer and by Equation 29 for flexible spacers. In all
cases we consider a divalent receptor with a distance d = 5 nm
between the binding pockets. Each binding pocket has a binding
range σ = 0.1 nm. In all three subfigures we see that if Kmono is
too large, i.e., if the monovalent binder is too weak, the RBA-
Beilstein J. Org. Chem. 2015, 11, 804–816.
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value never reaches 1. In such a situation, using the RBA-value
as a quantifier, the monovalent ligand binds always better than
the divalent ligand. Furthermore, at a certain Kmono, which we
will further on denote as , there is exactly one spacer
length, parameterized by rete, for which monovalent and diva-
lent ligands bind equally well. If Kmono is lower than ,
there is a broader range of spacer lengths for which the divalent
ligand binds better than the monovalent ligand (RBA > 1). In
Figure 5a the behavior of a stiff spacer with persistence length
lp = 53 nm is depicted, which mimics a DNA spacer to which
the ligand units are directly attached. A DNA spacer with a
contour length of 5 nm exhibits fluctuations in the range Δr ≈
0.05 nm, which is considerably smaller than the binding range
σ. As is discussed in the previous section, the maximum and
width of the effective concentration and therefore also the
maximum and width of the RBA are in this case determined by
the binding range σ. In Figure 5b we assume a DNA spacer that
is decorated with flexible PEG linkers at both ends. The PEG
linkers consist of four monomers each. Assuming Gaussian-
chain behavior with a segment length of b = 0.38 nm [29], the
fluctuations of the PEG linkers and hence the fluctuations of the
whole ligand sum up to Δr = 0.5 nm. The shape of the RBA now
is much broader, showing that the ligand is less affected by a
mismatch between spacer length and distance between the
binding pockets. Additionally, we obtain  = 5 mM in
Figure 5b which is considerably smaller than  = 28 mM
for the pure DNA spacer in Figure 5a. The same trend is
continued in Figure 5c. The more flexible the spacer, the
smaller is , indicating that flexible spacers are less suit-
able to improve the binding affinity of weak monovalent
binders, even though they are more tolerant with respect to a
mismatch between linker length and receptor distance.
To investigate the transition from RBA < 1 to RBA > 1 further,
we determine the critical dissociation constant  for which
the RBA is equal to one for the optimized chain length, i.e., for
the chain length that maximizes the RBA value. Using
Equation 41 and Equation 47 it can easily be seen that 
relates to the effective concentration  as
(48)
In Figure 6,  is shown for stiff as well as flexible ligands.
The stiff ligand is considered to consist of a DNA spacer to
which the ligand units are attached via two PEG linkers. Linker
length and binding range are set to be identical to the example
presented in Figure 5b. The average end-to-end distance of the
DNA spacer is either chosen to be equal to d (black, continuous
line), or is chosen to be too short by 0.7 nm, which mimics the
length of two base pairs (red, continuous line). Even though the
mismatch between spacer length and binding pocket distance is
small, the ligand becomes significantly less efficient.
The flexible ligand is chosen to resemble a PEG spacer. Again,
we assume Gaussian-chain behavior with a segment length of
b = 0.38 nm. A ligand with optimized spacer length (black,
dashed line) does not exhibit a significant difference to a ligand
with a spacer that is shortened by two segments (red, dashed
line). This shows again that a flexible chain is more tolerant
with respect to a distance mismatch between inter-binding
pocket distance d and chain length.
If the monovalent dissociation constant is larger than , a
monovalent ligand always binds better than a divalent ligand.
On the other hand, if the monovalent dissociation constant is
smaller than , a divalent ligand of optimally (or slightly
suboptimal) chosen size binds better than a monovalent ligand.
As can be seen in Figure 6,  depends on the distance
between the binding pockets as well as the spacer length and
flexibility. In order to approximate an upper limit for ,
the maximum effective concentration (Equation 24 for a flex-
ible spacer and Equation 15 and Equation 16 for a stiff spacer)
is substituted into Equation 48:
(49)
(50)
As an example that is relevant for medical applications we want
to briefly discuss the interaction between hemagglutinin (HA), a
receptor protein on the surface of influenza viruses, and its
ligand sialic acid (SA). The dissociation constant between
monomeric SA and trimeric HA is known to be 2.5 mM [1].
Furthermore, the crystal structure of HA [30] indicates a dis-
tance between neighboring binding pockets in the range of
d = 5 nm. Note that HA is a trivalent receptor, which means that
additional binding modes as well as different numbers of
permutations (see Figure 1b) have to be considered. Neverthe-
less, since the efficiency of a divalent ligand is mainly influ-
enced by the effective concentration  and the monovalent
dissociation constant Kmono, rather than by the number of
binding modes, we can compare the values for the SA–HA pair
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with the results presented in Figure 6. We see that a divalent
ligand consisting of two SA units connected via a PEG spacer is
expected to bind less efficient than the monovalent SA. In
contrast, a stiff DNA spacer can increase the binding affinity of
the divalent ligand compared to the monovalent ligand, if its
length is optimized.
Figure 6: Efficiency diagram:  is shown for different
ligand–spacer constructs. If the monovalent dissociation constant is
larger than , a monovalent ligand always binds better than a
divalent ligand. If, on the other hand, the monovalent dissociation
constant is smaller than , a divalent ligand of suitably chosen
length binds better than its monovalent counterpart. We present 
in dependence of the distance between the binding pockets for a DNA
spacer with flexible PEG linkers (Δr = 0.5 nm). In the optimal case, the
spacer length is chosen equal to the distance d (black, continuous
line). In the slightly suboptimal case, the spacer length is chosen to be
0.7 nm (two base pairs) shorter than the distance d (red, continuous
line). In both cases the binding range is set to σ = 0.1 nm. We also
show  for a flexible PEG spacer with optimized spacer length
(black, dashed line) and a spacer that is two monomers shorter
(≈0.76 nm) (red, dashed line). The monovalent dissociation constant
 as well as the distance between neighboring binding pockets
for a SA–HA pair is indicated by a black point.
Conclusion
In the present work we first examine different polymeric
models for the effective concentration. We find that a worm-
like-chain model can be well reproduced by a simple harmonic
spring model and a Gaussian-chain model with suitable chosen
parameters, in the stiff and flexible limits, respectively. We next
study the binding between divalent ligand–receptor pairs. We
find that multivalency increases the overall binding affinity
only, if the monovalent ligand–receptor pair binds strongly
enough, i.e.; if the monovalent dissociation constant is smaller
than a critical value . Approximations for  for both
flexible and stiff ligands are derived in dependence of the dis-
tance between the binding pockets and the spacer length and
flexibility. For the optimal ligand design, we find that for stiff
ligands the average end-to-end distance should be equal to the
distance between the binding pockets and the average fluctua-
tions should be of the order, but not smaller, than the binding
range. The average end-to-end distance of a flexible ligand on
the other side should be smaller by a factor of  than the
binding pocket distance d.
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